Loading insider details...
Beta
Latest Form 4 (May 21, 2026): Grant/Award of 24,122 PHAT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 24,122 | n/a |
| Jan 8, 2026 | Cidara Therapeutics, Inc. (CDTX) | Disposition to Issuer | 7,526 | $1.67M |
| Dec 13, 2025 | Cidara Therapeutics, Inc. (CDTX) | Tax Withholding | 7,290 | $1.60M |
| Jun 5, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 10,500 | n/a |
| Feb 26, 2025 | Cidara Therapeutics, Inc. (CDTX) | Grant/Award | 57,500 | n/a |
| Dec 16, 2024 | Phathom Pharmaceuticals, Inc. (PHAT) | Purchase | 12,500 | $99.1K |
| May 31, 2024 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 25,000 | $254.1K |
| May 24, 2024 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 10,500 | n/a |
| Dec 20, 2023 | Better Therapeutics, Inc. (BTTX) | Grant/Award | 62,500 | n/a |
| Jul 31, 2023 | Better Therapeutics, Inc. (BTTX) | Purchase | 137,005 | $100.0K |